DRI Capital Inc. is a Toronto-based healthcare royalty fund manager, a type of private equity fund. Its CEO is Behzad Khosrowshahi, the eldest child and only son of Hassan Khosrowshahi. It specializes in purchasing robust and predictable royalty streams from established pharmaceutical drugs, providing a consistent and diversified revenue stream to investors. In 2013, the firm closed a third fund of $1 billion. As of June 30, 2013, the firm had purchased 41 royalty streams from 29 different leading pharmaceutical products.